News About: Med. Insurance
Court upholds SNUH’s redemption of 4.1 billion won in medication costs
A Seoul court has ruled that the Seoul National University Hospital’s redemption request of 4.1 billion won in medication costs was justified because SNUH doctors prescribed necessary drugs based on their medical rati...
National health insurance not to cover reissued prescription, HIRA says
Patients who want to reissue the prescription after losing dispensed medicines carelessly will exclude from the national health insurance benefits, according to the Health Insurance Review & Assessment Service (HIRA)....
HIRA considers positive list system inevitable option
The controversial positive list system should be regarded as an inevitable option, which will drastically reduce the nation's medical insurance burden, according to the Health Insurance Review & Assessment Service (HI...
Wholesalers call for margin increase
The Seoul chapter for the Korea Association of Pharmaceutical Wholesaler has strongly urged Daewoong Pharm to increase wholesaler margin, which was agreed by both parties two years ago.
Wholesalers in Seoul will so...
Hepatitis B patients with renal failure to benefit from more health insurance
Hepatitis B patients with renal insufficiency will have more health insurance allowance for clevudine as Bukwang completed its dose-modifying studies.
The company will make its additional license application to the...
Linkage of product license-insurance price registration eyed
The Korea Drug Research Association has called for the government to shorten the period of assessing the possible health insurance prices of all medicines, when these drugs are approved by the Korea Food and Drug Admi...
Korea reforms drug re-evaluation system
The government said it has changed the way it handles the drug re-evaluation system from August 8. These include safety and efficacy data from the three-year usage at home as well as that of foreign countries.
The ...
NHIC, Daewon poles apart on medicine negotiation
The National Health Insurance Corporation and Daewon Pharm remain far apart in their negotiations over the price evaluation of home-grown Peluvi tablets (felubiprofen), new NSAID (nonsteroidal anti-inflammatory drug) ...
Hospitals and pharmacies to face punishment over illegal request
The government will crack down on some hospitals and clinics for their illegal requests for health insurance benefits, according to the Ministry of Health, Welfare and Family Affairs.
The ministry said on July 29 t...
Economic effectiveness of medicines to be under debate
With the government’s plan to make public its final assessment of economic effectiveness over antihyperlipidemic agents sooner or later, drug makers are calling for the government to establish more rational standard f...
